Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (61-70 of 304) with videos related to

Pageof 31
Sort By:
Current Cancer Drug Targets|December 9, 2020
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung TissuesKarthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, et al.
International Journal of Molecular Sciences|April 13, 2023
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing PathwayChiara Massa, Yuan Wang, Nico Marr, et al.
Archives of Dermatological Research|December 24, 2008
CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cellsMarkus Meissner, Theresa L Whiteside, Roland Kaufmann, et al.
Journal of the National Cancer Institute|April 7, 2017
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune EscapeStefan B Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
Cancers|April 3, 2021
Relevance of 2'-O-Methylation and Pseudouridylation for the Malignant MelanomaSimon Jasinski-Bergner, Juliane Blümke, Claudia Wickenhauser, et al.
Advances in Anatomic Pathology|December 14, 2022
Cancer Immunology: Immune Escape of Tumors-Expression and Regulation of HLA Class I Molecules and Its Role in ImmunotherapiesYuan Wang, Simon Jasinski-Bergner, Claudia Wickenhauser, et al.
Cellular and Molecular Life Sciences : CMLS|November 11, 2010
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Laurence Amiot, Soldano Ferrone, Hans Grosse-Wilde, et al.
Frontiers in Immunology|November 1, 2021
The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune RecognitionAbigael Eva Chaouat, Barbara Seliger, Ofer Mandelboim, et al.
Frontiers in Immunology|March 3, 2022
Role of HLA-G in Viral InfectionsSimon Jasinski-Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Proteomics|December 12, 2007
Candidate biomarkers in renal cell carcinomaBarbara Seliger, Sven P Dressler, Rudolf Lichtenfels, et al.
Pageof 31

Showing results (61-70 of 304) with videos related to

Sort By:
Pageof 31
Current Cancer Drug Targets|December 9, 2020
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung TissuesKarthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, et al.
International Journal of Molecular Sciences|April 13, 2023
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing PathwayChiara Massa, Yuan Wang, Nico Marr, et al.
Archives of Dermatological Research|December 24, 2008
CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cellsMarkus Meissner, Theresa L Whiteside, Roland Kaufmann, et al.
Journal of the National Cancer Institute|April 7, 2017
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune EscapeStefan B Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
Cancers|April 3, 2021
Relevance of 2'-O-Methylation and Pseudouridylation for the Malignant MelanomaSimon Jasinski-Bergner, Juliane Blümke, Claudia Wickenhauser, et al.
Advances in Anatomic Pathology|December 14, 2022
Cancer Immunology: Immune Escape of Tumors-Expression and Regulation of HLA Class I Molecules and Its Role in ImmunotherapiesYuan Wang, Simon Jasinski-Bergner, Claudia Wickenhauser, et al.
Cellular and Molecular Life Sciences : CMLS|November 11, 2010
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Laurence Amiot, Soldano Ferrone, Hans Grosse-Wilde, et al.
Frontiers in Immunology|November 1, 2021
The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune RecognitionAbigael Eva Chaouat, Barbara Seliger, Ofer Mandelboim, et al.
Frontiers in Immunology|March 3, 2022
Role of HLA-G in Viral InfectionsSimon Jasinski-Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Proteomics|December 12, 2007
Candidate biomarkers in renal cell carcinomaBarbara Seliger, Sven P Dressler, Rudolf Lichtenfels, et al.
Pageof 31